We were fortunate to have the opportunity to catch-up with Kristl Vonck (Ghent University Hospital, Ghent, Belgium) at EAN 2019. She talked to us about the topic of her recently published article: Measuring the Effects of Neurostimulation in Drug-resistant Epilepsy and Depression.
1. How common is drug-resistant epilepsy? (0:04)
2. What neurostimulation methods are available for these patients? (0:30)
3. How can we identify which patients are most likely to respond to neurostimulation (2:25)?
Speaker disclosure: Kristl Vonck has received grant support, consultancy and speaker fees from LivaNova Inc. and Medtronic.
Filmed at the 5th Congress of the European Academy of Neurology (EAN), Oslo, Norway, June 2019.
Share this Video
Related Videos In Epilepsy
Michael Sperling, AAN 2021: Post-hoc Analysis of Cenobamate for Uncontrolled Focal Seizures
We were delighted to speak with Michael Sperling (Thomas Jefferson University, Philadelphia, PA, USA) to discuss the recent post-hoc analysis of cenobamate for uncontrolled focal seizures, and its intended place in the treatment landscape for epilepsy. The abstract entitled: ‘Efficacy of Cenobamate for Uncontrolled Focal Seizures: Post-hoc Analysis of a Phase 3, Multicenter, Open-Label Study’ […]
Pat Penovich, AES 2020 – The Patient Experience With Diazepam Nasal Spray
It was a pleasure to talk to Pat Penovich (Minnesota Epilepsy Group, St. Paul, MN, USA) about the exit survey, of a Phase 3 study, assessing patient experience of using the diazepam nasal spray for seizure clusters. The abstract ‘Examining the Patient Experience With Diazepam Nasal Spray for Seizure Clusters: Patient-reported Results From an Exit […]
Martin Brodie, CONy 2020 – Combination Antiepileptic Drug Therapy
It was a pleasure to speak with Martin Brodie (President, International Bureau for Epilepsy and co-Section Head of Epilepsy for CONy), who spoke with us on the topic of the debate session he participated in: Should combination antiepileptic drug (AED) therapy be offered immediately after failure of a single antiepileptic drug? Questions Could you tell […]
Journal articles and more to your inbox
Get the latest clinical insights from touchNEUROLOGYSign me up!